Видео ютуба по тегу Event: Gu Cancers 2021

Highlights in Urologic Oncology From 2021 ASCO GU Cancers Symposium
Highlights in Urologic Oncology From 2021 ASCO GU Cancers Symposium
Expert video report on Prostate Cancer from 2021 Genitourinary Cancers Symposium
Expert video report on Prostate Cancer from 2021 Genitourinary Cancers Symposium
2021 ASCO Direct Jacksonville | Genitourinary Cancers Panel Discussion
2021 ASCO Direct Jacksonville | Genitourinary Cancers Panel Discussion
HOPA BCOP Genitourinary Cancers Updated Jan 2021
HOPA BCOP Genitourinary Cancers Updated Jan 2021
Highlights in bladder cancer from ASCO GU 2021
Highlights in bladder cancer from ASCO GU 2021
3rd Knowledge Series for Genitourinary Cancers Year In Review 2021 8 May
3rd Knowledge Series for Genitourinary Cancers Year In Review 2021 8 May
2021 West Oncology | Genitourinary Cancers | Panel Discussion and Q&A
2021 West Oncology | Genitourinary Cancers | Panel Discussion and Q&A
Take a tour of the 2021 B2B GU Cancers Triad Virtual Meeting Platform!
Take a tour of the 2021 B2B GU Cancers Triad Virtual Meeting Platform!
2021 ASCO Direct San Francisco | Genitourinary Cancers Panel Discussion
2021 ASCO Direct San Francisco | Genitourinary Cancers Panel Discussion
LARVOL Oncology Panel: ASCO GU 2021
LARVOL Oncology Panel: ASCO GU 2021
2021 ASCO Direct St. Louis | Genitourinary Cancers Panel Discussion
2021 ASCO Direct St. Louis | Genitourinary Cancers Panel Discussion
ASCO 2021 Clinical Panel Series - Genitourinary Cancers
ASCO 2021 Clinical Panel Series - Genitourinary Cancers
2021 West Oncology | Genitourinary Cancers | Emerging Therapies in Renal Cancer
2021 West Oncology | Genitourinary Cancers | Emerging Therapies in Renal Cancer
Highlights in kidney and bladder cancer at ASCO GU 2021
Highlights in kidney and bladder cancer at ASCO GU 2021
Highlights in urothelial cancer for ASCO GU 2021
Highlights in urothelial cancer for ASCO GU 2021
Dr. Wei on Immune-Related Adverse Events in GU Cancers
Dr. Wei on Immune-Related Adverse Events in GU Cancers
Key updates in bladder cancer from ASCO GU 2021
Key updates in bladder cancer from ASCO GU 2021
ASCO GU 2021 highlights: enfortumab vedotin, oral docetaxel and 177Lu-PSMA-617
ASCO GU 2021 highlights: enfortumab vedotin, oral docetaxel and 177Lu-PSMA-617
Trial updates from ASCO GU 2021: SPIRE, NEO-BLADE, P3BEP and SAPROCAN
Trial updates from ASCO GU 2021: SPIRE, NEO-BLADE, P3BEP and SAPROCAN
ASCO GU 2021 - Abstract 239 and 240
ASCO GU 2021 - Abstract 239 and 240